 |
|
Femoral vs Jugular Venous Catheterization and Risk of Nosocomial Events in Adults Requiring Acute Renal Replacement TherapyA Randomized Controlled Trial
Jean-Jacques Parienti, MD, DTM&H;
Marina Thirion, MD;
Bruno Mégarbane, MD, PhD;
Bertrand Souweine, MD, PhD;
Abdelali Ouchikhe, MD;
Andrea Polito, MD;
Jean-Marie Forel, MD;
Sophie Marqué, MD;
Benoît Misset, MD;
Norair Airapetian, MD;
Claire Daurel, MD;
Jean-Paul Mira, MD, PhD;
Michel Ramakers, MD;
Damien du Cheyron, MD, PhD;
Xavier Le Coutour, MD;
Cédric Daubin, MD;
Pierre Charbonneau, MD; for Members of the Cathedia Study Group
JAMA. 2008;299(20):2413-2422.
Context Based on concerns about the risk of infection, the jugular site is often preferred over the femoral site for short-term dialysis vascular access.
Objective To determine whether jugular catheterization decreases the risk of nosocomial complications compared with femoral catheterization.
Design, Setting, and Patients A concealed, randomized, multicenter, evaluator-blinded, parallel-group trial (the Cathedia Study) of 750 patients from a network of 9 tertiary care university medical centers and 3 general hospitals in France conducted between May 2004 and May 2007. The severely ill, bed-bound adults had a body mass index (BMI) of less than 45 and required a first catheter insertion for renal replacement therapy.
Intervention Patients were randomized to receive jugular or femoral vein catheterization by operators experienced in placement at both sites.
Main Outcome Measures Rates of infectious complications, defined as catheter colonization on removal (primary end point), and catheter-related bloodstream infection.
Results Patient and catheter characteristics, including duration of catheterization, were similar in both groups. More hematomas occurred in the jugular group than in the femoral group (13/366 patients [3.6%] vs 4/370 patients [1.1%], respectively; P = .03). The risk of catheter colonization at removal did not differ significantly between the femoral and jugular groups (incidence of 40.8 vs 35.7 per 1000 catheter-days; hazard ratio [HR], 0.85; 95% confidence interval [CI], 0.62-1.16; P = .31). A prespecified subgroup analysis demonstrated significant qualitative heterogeneity by BMI (P for the interaction term < .001). Jugular catheterization significantly increased incidence of catheter colonization vs femoral catheterization (45.4 vs 23.7 per 1000 catheter-days; HR, 2.10; 95% CI, 1.13-3.91; P = .017) in the lowest tercile (BMI <24.2), whereas jugular catheterization significantly decreased this incidence (24.5 vs 50.9 per 1000 catheter-days; HR, 0.40; 95% CI, 0.23-0.69; P < .001) in the highest tercile (BMI >28.4). The rate of catheter-related bloodstream infection was similar in both groups (2.3 vs 1.5 per 1000 catheter-days, respectively; P = .42).
Conclusion Jugular venous catheterization access does not appear to reduce the risk of infection compared with femoral access, except among adults with a high BMI, and may have a higher risk of hematoma.
Trial Registration clinicaltrials.gov Identifier: NCT00277888
Author Affiliations: Departments of Biostatistics and Clinical Research (Drs Parienti and Le Coutour), Medical Intensive Care (Drs Parienti, Ramakers, du Cheyron, Daubin, and Charbonneau), Surgical Intensive Care (Dr Ouchikhe), and Microbiology (Dr Daurel), Côte de Nacre University Hospital Center, Caen; Department of Medical Intensive Care, Cochin University Hospital Center, Paris (Drs Thirion, Marqué, and Mira); INSERM U567, Cochin Institute, University of Paris Descartes, Faculty of Medicine, Paris (Dr Mira); Department of Medical Intensive Care, Lariboisière University Hospital Center, Paris, and University of Paris VII (Dr Mégarbane); Departments of Medical Intensive Care and Nephrology, University Hospital Center, Clermont-Ferrand (Dr Souweine); Department of Medical Intensive Care, University Hospital Center, Garches (Dr Polito); Department of Medical Intensive Care, University Hospital Center, Marseille (Dr Forel); Department of Medical-Surgical Intensive Care, Saint-Joseph Hospital, and Faculty of Medicine, University of Paris Descartes, Paris (Dr Misset); and Departments of Medical Intensive Care and Nephrology, University Hospital Center, Amiens (Dr Airapetian), France. Dr Thirion is now with the Department of Medical-Surgical Intensive Care, Argenteuil, France; Dr Ouchikhe is now with the Department of Anaesthesiology, General Hospital, Saintes, France; Dr Marqué is now with the Department of Medical Intensive Care, University Hospital, Rennes, France; and Dr Airapetian is now with the Department of Surgical Intensive Care, Amiens, France.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Femoral vs Jugular Venous Catheterization for Short-term Dialysis Access
Saravanan Balamuthusamy, Ivo Lukitch, and Eric E. Simon
JAMA. 2008;300(15):1760-1761.
EXTRACT
| FULL TEXT
Femoral vs Jugular Venous Catheterization for Short-term Dialysis Access
Lewis Eisen
JAMA. 2008;300(15):1761.
EXTRACT
| FULL TEXT
Femoral vs Jugular Venous Catheterization for Short-term Dialysis Access—Reply
Jean-Jacques Parienti
JAMA. 2008;300(15):1761-1762.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Staphylococcus aureus Infections in Hemodialysis: What a Nephrologist Should Know
Vandecasteele et al.
CJASN 2009;4:1388-1400.
ABSTRACT
| FULL TEXT
Update in Critical Care 2008
Fowler et al.
Am. J. Respir. Crit. Care Med. 2009;179:743-758.
FULL TEXT
Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial
Biffi et al.
Ann Oncol 2009;20:935-940.
ABSTRACT
| FULL TEXT
Femoral vs Jugular Venous Catheterization for Short-term Dialysis Access
Eisen
JAMA 2008;300:1761-1761.
FULL TEXT
Femoral vs Jugular Venous Catheterization for Short-term Dialysis Access
Balamuthusamy et al.
JAMA 2008;300:1760-1761.
FULL TEXT
|
